Literature DB >> 24032645

Immunological changes and increased expression of myxovirus resistance protein a in thyroid tissue of patients with recent onset and untreated Graves' disease.

Sara Salehi Hammerstad1, Frode Lars Jahnsen, Sisko Tauriainen, Heikki Hyöty, Trond Paulsen, Ingrid Norheim, Knut Dahl-Jørgensen.   

Abstract

BACKGROUND: Few studies have systematically examined the immune cells that infiltrate thyroid tissue at the time of the onset of Graves' disease (GD). The role of viruses in the pathogenesis of autoimmune thyroid diseases is controversial. The present study analyzed inflammatory responses with respect to signs of virus infection.
METHODS: Thyroid tissue was obtained from 22 patients with newly diagnosed and untreated GD, 24 patients with chronic GD, and 24 controls. Inflammation was assessed by immunostaining for CD4+ and CD8+ T cells, plasma cells (CD138+), and plasmacytoid dendritic cells (PDCs). The production of interferon-inducible myxovirus resistance protein A (MxA) was analyzed as a sign of virus infection.
RESULTS: The degree of thyroid inflammation and fibrosis was significantly higher in both patient groups compared with that in controls. The number of CD4+ T cells and plasma cells (activated B cells) was significantly higher in both patient groups. CD8+ cells were only present in patients with chronic disease. MxA expression and the number of PDCs increased only in patients with newly diagnosed GD. There was a strong positive correlation between the number of PDCs and the number of MxA+ leucocytes.
CONCLUSION: The increase in CD8+ T cells during the chronic stage of GD suggests that they may play a role in progression of the autoimmune process from early to chronic thyroiditis. Upregulation of MxA expression during the early stages of the disease, and the positive correlation between the number of PDCs and the number of MxA+ leucocytes, suggests that activated PDCs secrete type I IFNs at the lesion site, possibly in response to viral infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24032645     DOI: 10.1089/thy.2013.0287

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  4 in total

1.  Iodine-131 therapy alters the immune/inflammatory responses in the thyroids of patients with Graves' disease.

Authors:  Wenhua Du; Qingyu Dong; Xiaoting Lu; Xiaomeng Liu; Yueli Wang; Wenxia Li; Zhenyu Pan; Qian Gong; Cuige Liang; Guanqi Gao
Journal:  Exp Ther Med       Date:  2017-01-16       Impact factor: 2.447

2.  Expansion of inflammatory monocytes in periphery and infiltrated into thyroid tissue in Graves' disease.

Authors:  Xinxin Chen; Yanqiu Wang; Yicheng Qi; Jiqi Yan; Fengjiao Huang; Mengxi Zhou; Weiqing Wang; Guang Ning; Yulin Zhou; Shu Wang
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

3.  Graves' Disease Patients with Persistent Hyperthyroidism and Diffuse Lymphoplasmacytic Infiltration in the Thyroid Show No Histopathological Compatibility with IgG4-Related Disease.

Authors:  Eijun Nishihara; Mitsuyoshi Hirokawa; Mitsuru Ito; Shuji Fukata; Hirotoshi Nakamura; Nobuyuki Amino; Akira Miyauchi
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

4.  HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease.

Authors:  Therese Weider; Sarah J Richardson; Noel G Morgan; Trond H Paulsen; Knut Dahl-Jørgensen; Sara Salehi Hammerstad
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.